Biomensio offers a multianalyte biosensing platform that enables rapid, label-free detection of multiple biological targets from a single droplet of sample using a handheld device. This technology addresses the need for quick and accurate diagnostics in various applications, including food safety, human health, and drug testing, by providing real-time results that can be easily integrated into cloud-based analytics.
Funding
$14M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current laboratory-based bioanalytical methods often require specialized equipment and trained personnel, leading to delays and increased costs, especially in point-of-need applications. Traditional methods also typically analyze for a single target at a time, limiting the efficiency of comprehensive screening.
Solution
Biomensio offers a portable, multianalyte biosensing platform that enables rapid, label-free detection of multiple biological targets from a single droplet of sample. The handheld reader utilizes a mass-sensitive microarray sensor integrated into a fluidic cartridge, allowing for on-site testing without the need for complex sample preparation or external labels. The system delivers real-time binding curves, integrates multiple controls to minimize false positives, and transfers test results to a cloud-based analytics service or customer-specific API for immediate data analysis and decision-making. This technology facilitates the fast development of new bio-screening applications for on-site testing.
Target Audience
The primary target audience includes professionals in food safety, human health, veterinary medicine, and forensics who require rapid, accurate, and on-site bioanalytical testing.
Features
- Mass-sensitive microarray sensor for label-free detection of multiple analytes
- Integrated fluidic cartridge for easy sample loading and handling
- Handheld reader for portable, on-site testing
- Real-time binding curves for accurate measurements
- Multiplexing capability for simultaneous detection of tens of analytes
- Cloud connectivity for data analytics and reporting
- Scalable manufacturing process utilizing existing high-volume production technologies